Cargando…
MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1
Endometrial cancer (EC) is one of the most commonly diagnosed gynecologic malignancies in the world, with the morbidity rate of over 7%. The mechanism of the pathogenesis has not been specifically elucidated to date, which is imperative for EC treatment. The aim of our study was to investigate the t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663604/ https://www.ncbi.nlm.nih.gov/pubmed/29137432 http://dx.doi.org/10.18632/oncotarget.21037 |